A cohort of scientists from the Wellcome Sanger Institute, the University of Cambridge, the Peter Doherty Institute for Infection and Immunity and the University of Queensland have identified novel targets using DNA sequencing, bringing research one step closer to developing a universal vaccine against Group A Streptococcus.
Researchers have compiled the most comprehensive collection of human intestinal bacteria to date, isolating over 100 bacterial species from healthy individuals for the first time.
The largest population study of hepatitis C in Africa has discovered three new strains of the virus with unknown susceptibility to currently used antiviral treatments.
Researchers at Stanford University School of Medicine have reported that the most common origin of bloodstream infections, during a hospital stay, as a consequence of the patient’s own gut.
The new species, the Bombali virus, has been identified in bats in Sierra Leone ahead of any human infection.
Take a look at how portable, long-read nanopore sequencing can be applied to the study of hepatitis B virus.
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
Scientists have analyzed whole-genome sequence data from a UK public health surveillance study to reveal new understandings of the Salmonella epidemic in sub-Saharan Africa.
This study characterizes 23 nonserotypeable Shigella using whole genome sequencing, discovering this approach for Shigella O-antigen analysis has greater discriminative power than other methods using different bioinformatics pipeline for identification of nonserotypeable Shigella.
Genus-wide analysis of Penicillia highlights the potential to develop new antibiotics from nature.
